AALIYA BURZA
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease BROOKLYN, NY NPI 1477700425
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$4,656.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 57
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $156.96 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $140.72 | 7 |
| Education | $16.24 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $59.34 | 3 |
| Insmed, Inc. | $30.13 | 2 |
| Amgen Inc. | $28.30 | 1 |
| ABBVIE INC. | $24.51 | 1 |
| GlaxoSmithKline, LLC. | $14.68 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089555770 | Insmed, Inc. | $13.89 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1089557838 | Insmed, Inc. | $16.24 | 05/21/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1103396615 | ABBVIE INC. | $24.51 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104524918 | AstraZeneca Pharmaceuticals LP | $17.02 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104583920 | AstraZeneca Pharmaceuticals LP | $26.52 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105783846 | AstraZeneca Pharmaceuticals LP | $15.80 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111540159 | Amgen Inc. | $28.30 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116377782 | GlaxoSmithKline, LLC. | $14.68 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.